Institutional investors purchased a net $723.4 thousand shares of ANAB during the quarter ended June 2019 and now own 104.92% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SATURN V CAPITAL MANAGEMENT LLC Bought 577.1 Thousand shares of AnaptysBio Inc
SUVRETTA CAPITAL MANAGEMENT LLC Bought 479.4 Thousand shares of AnaptysBio Inc
FIRST LIGHT ASSET MANAGEMENT LLC Bought 468.6 Thousand shares of AnaptysBio Inc